Farther Finance Advisors, LLC Xencor Inc Transaction History

Farther Finance Advisors, LLC

  • $1.64 Trillion
  • Q1 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024
SELL
$18.65 - $26.52 $111 - $159
-6 Closed
0 $0
Q4 2023

Feb 14, 2024
BUY
$16.53 - $21.42 $33 - $42
2 New
2 $42,000
Q1 2023

May 13, 2024
BUY
$25.95 - $36.95 $103 - $147
4 Added 200.0%
6 $167,000
Q4 2022

Sep 11, 2023
BUY
$24.79 - $30.86 $148 - $185
6 New
6 $156,000

Others Institutions Holding XNCR

# of Institutions
203
Shares Held
64M
Call Options Held
2.2K
Put Options Held
1.3K
View Full List

About Xencor Inc

XNCR Quotes by TradingView
  • Ticker XNCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,698,100
  • Market Cap $1.13B
  • Description
  • Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...
More about XNCR
Track This Portfolio

Track Farther Finance Advisors, LLC Portfolio

Follow Farther Finance Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Farther Finance Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Farther Finance Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email